Unstructured summary
Children represent both a clinically important population susceptible to tuberculosis, but also a key group in whom to study intrinsic and vaccine-induced mechanisms of protection. Following exposure to Mycobacterium tuberculosis, young children are at high risk of progressing first to tuberculosis infection, then tuberculosis disease and possibly disseminated forms of tuberculosis, with accompanying high morbidity and mortality. Younger school-age children are relatively protected, before risk increases again in adolescence. Furthermore, children are the only group for whom there is proven benefit of Bacillus Calmette-Guérin (BCG) immunization. Case-control comparisons from key cohorts, which recruited more than 15,000 children and young people between them, have identified the monocyte:lymphocyte ratio, activated CD4 T cells, and an RNA signature as correlates of risk for developing tuberculosis. Further studies of protected and susceptible populations are necessary to guide development of novel tuberculosis vaccines that could facilitate the goal of zero childhood tuberculosis deaths.